Investigational Drug Information for Vestipitant
✉ Email this page to a colleague
What is the development status for investigational drug Vestipitant?
Vestipitant is an investigational drug.
There have been 7 clinical trials for Vestipitant.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2004.
The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Vomiting, and Anxiety Disorders. The leading clinical trial sponsors are GlaxoSmithKline, Accenture, and [disabled in preview].
Summary for Vestipitant
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 204 |
| WIPO Patent Applications | 107 |
| Japanese Patent Applications | 49 |
| Clinical Trial Progress | Phase 2 (2004-11-01) |
| Vendors | 13 |
Recent Clinical Trials for Vestipitant
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV) | Accenture | Phase 2 |
| Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV) | Accenture | Phase 1 |
| Vestipitant 28-day Tolerance Study | GlaxoSmithKline | Phase 2 |
Clinical Trial Summary for Vestipitant
Top disease conditions for Vestipitant
Top clinical trial sponsors for Vestipitant
US Patents for Vestipitant
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
